glp-1 receptors in the brain and Degenerating Brain: Exploring Mechanistic Insights and Therapeutic Potential Glucagon-like Peptide-1 and the Central/Peripheral

Ending obesity coverage for GLP-1 obesity drugs could improve the states finances but might also result in health inequities and less comprehensive coverage, the states health and human services agency acknowledged in its September budget request

Legal claims assert that GlaxoSmithKline, the manufacturer of Alli, did not properly warn users about the potential for liver toxicity, especially among individuals with preexisting conditions or those who were using the drug for extended periods

Reducing Glucagon Secretion: GLP-1 inhibits the secretion of glucagon, a hormone that increases blood sugar levels by promoting the release of glucose from the liver

In one meta-analysis of RCTs, metformin worked about three times as well when starting a new antipsychotic in first-episode psychosis (about a 13-pound difference from placebo) compared with its use after chronic antipsychotic treatment (about a 4-pound difference from placebo) (De Silva VA et al, BMC Psychiatry 2016;16(1):341)

The provider must send a prescription for one of the covered GLP-1 drugs to a pharmacy and fill out a prior authorization form

(200 g kg 1 , 50 nmol kg 1 )) formulated at 20 g mL 1 in PBS 1